I-lithium orotateizongezo ziye zafumana ukuthandwa kwiminyaka yakutshanje ngenxa yeenzuzo zabo zempilo ezinokubakho. Nangona kunjalo, kusekho ukudideka kunye nolwazi olungeyonyani olujikeleze le minerali kunye nokusetyenziswa kwayo kwifomu yokuncedisa. Kule khokelo ebanzi, siya kugubungela yonke into oyifunayo ukuze ukwazi malunga ne-lithium orotate supplements.Okokuqala kwaye kubaluleke kakhulu, kubalulekile ukuqonda ukuba i-lithium orotate iyiminerali yendalo esetyenziselwa ukuxhasa impilo yengqondo kunye nokuphila kakuhle. Yindlela ye-lithium edibaniswe ne-orotic acid, enceda i-mineral ingene kwi-membrane yeseli ngokufanelekileyo. Oku kuthetha ukuba amanani aphantsi e-lithium orotate angasetyenziswa xa kuthelekiswa nezinye iindlela ze-lithium, ukunciphisa umngcipheko wemiphumo emibi.
Ziziphi iingenelo ze-lithium kwingqondo?
I-Lithium orotate yityuwa eyenziwe yi-orotic acid kunye ne-lithium. Igama layo elipheleleyo lithi i-lithium orotate monohydrate (i-Orotic acid lithium ityuwa monohydrate), kunye nefomula yayo ye-molecular yi-C5H3LIN2O4H2O. I-Lithium kunye ne-orotic acid ion azibotshwanga ngokudibeneyo kodwa zinokuhlukana kwisisombululo ukuvelisa ii-ion ze-lithium zasimahla. Uphando lubonisa ukuba i-lithium orotate ifumaneka kwi-bioavailable ngaphezu kweziyobisi ze-lithium carbonate okanye i-lithium citrate (i-US FDA-evunyiweyo ngamachiza).
I-Lithium sisiyobisi esiqhele ukusetyenziswa kwezamayeza ukunyanga ukudakumba, ukuphazamiseka kwengqondo, kunye nezinye iingxaki zengqondo. Nangona kunjalo, izinga lokufunxa i-lithium carbonate okanye i-lithium citrate liphantsi, kwaye amanani aphezulu afunekayo ukuvelisa iziphumo zonyango. Ngoko ke, zineempembelelo ezinkulu kwaye zinetyhefu. Nangona kunjalo, idosi ephantsi ye-lithium orotate ineempembelelo zokunyanga ezihambelanayo kwaye ineziphumo ebezingalindelekanga ezimbalwa.
Kwangoko ngeminyaka yee-1970, i-lithium orotate yathengiswa njengesongezelelo sokutya kwizigulo ezithile zengqondo, ezifana nokusela utywala kunye nesifo se-Alzheimer.
Inxalenye yobungqina yile ilandelayo:
Isifo se-Alzheimer: Uphando lubonisa ukuba i-lithium orotate ine-bioavailability ephezulu kwaye ingenza ngokuthe ngqo kwi-mitochondria kunye ne-glial cell membranes ukunika inkxaso kunye nokukhuselwa kwe-neurons kunye nokulibaziseka okanye ukuphucula izifo ze-neurodeergenerative ezifana nesifo se-Alzheimer.
I-Neuroprotection kunye nokuphuculwa kwememori: Uphando lwamva nje kumayeza aseMelika lufumanise ukuba i-lithium ayinakunceda kuphela ukukhusela iiseli zengqondo ekufeni kwangaphambi kwexesha, inokukhuthaza ukuvuselelwa kweeseli zengqondo. Ke ngoko, i-lithium inokukhusela i-hippocampus emonakalweni kwaye igcine okanye iphucule umsebenzi wememori.
I-Mood stabilizers: I-lithium (i-lithium carbonate okanye i-lithium citrate) isetyenziselwa unyango ukunyanga ukudakumba kunye ne-bipolar disorder. Ngokufanayo, i-lithium orotate inomphumela. Ngenxa yokuba ithamo elisetyenzisiweyo lincinci kakhulu xa lithelekiswa nexesha elifanayo kunyaka ophelileyo, linyamezeleke kwaye lineziphumo ebezingalindelekanga ezimbalwa.
Ilungele ntoni i-lithium orotate?
Isifo sika-Alzheimer sisifo se-nervous system. Ngokweklinikhi, izigulana ziya kuba neempawu ezifana nokukhubazeka kwememori, i-amnesia, kunye nokungasebenzi kakuhle. Oyena nobangela wesi sifo awukafunyaniswa. Phakathi kwazo, isifo sika-Alzheimer sikwabizwa ngokuba sisifo sika-Alzheimer. Uninzi lwezigulana zihlakulela isifo ngaphambi kweminyaka engama-65. Eli qela lezifo ezingapheliyo ezibangelwa yizinto ezahlukeneyo. Ngaphezu koko, uninzi lwabaguli baba nesi sifo emva kweminyaka engama-50 ubudala. Kwiimpawu zokuqala, kuya kubakho ukulibala ngakumbi.
Kwinqanaba lokuqala, amandla eenkumbulo zesigulana aya kuhla ngokuthe ngcembe, ngokomzekelo, ngokukhawuleza uya kuyilibala into asandul’ ukuyithetha okanye into ayenzileyo, yaye amandla omguli okuhlalutya nendlela yokugweba nawo aya kuncipha, kodwa kwangaxeshanye, ezinye izinto. wafunda ngaphambili naye uya kuncipha. Isigulane siya kuba neenkumbulo zomsebenzi okanye ubuchule. Emva kokuba isifo sibe sibi, iimpawu zenqanaba lokuqala lesigulane ziya kubonakala ngokucacileyo ukukhubazeka kwengqondo ye-spatial, kwaye kuya kuba nzima ukunxiba.
Ngokukodwa, ukusetyenziswa kwe-lithium kwakudibene ne-44% yengozi ephantsi ye-dementia, i-45% ingozi ephantsi ye-Alzheimer's disease (AD), kunye ne-64% yengozi ephantsi ye-vascular dementia (VD).
Oku kuthetha ukuba iityuwa ze-lithium zinokuba yindlela yokuthintela isifo sengqondo esiyingozi esifana ne-AD.
I-dementia ibhekiselele kuphazamiseko oluqatha noluzingileyo lwengqondo. Ngokweklinikhi, kubonakala ngokuhla kancinci kwengqondo, okukhatshwa ngamanqanaba ahlukeneyo okutshintsha kobuntu, kodwa akukho kuphazamiseka kwengqondo. Liqela le-syndromes yeklinikhi kunokuba isifo esizimeleyo. Baninzi oonobangela besifo sengqondo esixhalabisayo, kodwa uninzi lwesifo sengqondo esiyingozi sisoloko sibangelwa kukonakala kwengqondo okanye izilonda zengqondo, ezifana nesifo sika-Alzheimer, isifo sikaParkinson, ukwenzakala kwengqondo okubuhlungu, njl.
Impembelelo ye-neuroprotective yeetyuwa ze-lithium
Uphononongo lweziphumo ze-lithium kwingqondo kunye negazi (Uphononongo lweziphumo ze-lithium kwingqondo kunye negazi) Olu phononongo luthi: "Kwizilwanyana, i-lithium ilawula i-neurotrophins, kubandakanywa ne-brain-derived neurotrophic factor (BDNF), i-nerve growth factor, i-nerve Trophin 3 (NT3) , kunye nezamkeli zezi zinto zokukhula kwingqondo.
I-Lithium ikwakhuthaza ukwanda kweeseli ze-stem, kubandakanya umongo wethambo kunye neeseli ze-neural stem kwindawo engaphantsi kwe-subventricular, striatum, kunye ne-forebrain. Ukukhuthazwa kweeseli ze-neural stem kunokuchaza ukuba kutheni i-lithium inyusa ukuxinana kweeseli zengqondo kunye nomthamo kwizigulana ezine-bipolar disorder. “
Ukongeza kwezi ziphumo zingasentla, i-lithium inokuphucula ukusebenza komzimba, ukulawula ukusebenza kwenkqubo ye-nervous central, i-sedation, i-tranquility, i-neuroprotection, kunye nokulawula ukuphazamiseka kwe-neurological. Uhlalutyo lwe-meta ezimbini kunye nolingo olulawulwa ngokungahleliwe luye lwavula iingcango ezintsha kunyango oluchasene ne-dementia, ebonisa ukuba i-lithium inefuthe elihle ekusebenzeni kwengqondo kwizigulane ezinokukhubazeka kwengqondo encinci (MCI) kunye ne-AD.
Ngubani ongafanele athathe i-lithium orotate?
Abasetyhini abakhulelweyo nabancancisayo
Abasetyhini abakhulelweyo nabancancisayo kufuneka baphephe ukuthatha i-lithium orotate. Ukusetyenziswa kwe-lithium orotate ngexesha lokukhulelwa kunye nokuncancisa akuzange kufundwe ngokubanzi, kwaye kukho ulwazi oluncinci olukhoyo malunga nokhuseleko lwayo kwaba bantu. Kubalulekile ukuba abafazi abakhulelweyo okanye abancancisayo badibane nomboneleli wabo wezempilo ngaphambi kokuba basebenzise naziphi na izongezo, kuquka i-lithium orotate, ukuqinisekisa ukhuseleko lomama kunye nosana.
Abantu abanesifo sezintso
I-lithium ikhutshwa ikakhulu kwizintso, kwaye abantu abanesifo sezintso banokuba semngciphekweni owongeziweyo wokuqokelelwa kwe-lithium emzimbeni. Oku kunokukhokelela kwityhefu ye-lithium, enokuthi ibeke ubomi esichengeni. Ke ngoko, abantu abanesifo sezintso kufuneka bakuphephe ukuthatha i-lithium orotate ngaphandle kokuba phantsi kweliso elibukhali lomboneleli wezempilo onokubeka iliso ekusebenzeni kwezintso kwaye ahlengahlengise idosi ngokufanelekileyo.
Abantu abaneemeko zentliziyo
I-Lithium orotate iye yaxelwa ukuba ibe nemiphumo enokubakho kwinkqubo ye-cardiovascular system, kubandakanywa utshintsho kwizinga lentliziyo kunye nesigqi. Abantu abaneemeko zentliziyo esele zikhona, ezifana ne-arrhythmias okanye isifo senhliziyo, kufuneka baqaphele xa beqwalasela ukusetyenziswa kwe-lithium orotate. Abantu abaneemeko zentliziyo kufuneka badibane nomboneleli wezempilo ngaphambi kokusebenzisa i-lithium orotate ukuvavanya iingozi ezinokuthi zibekho kunye neenzuzo ezisekelwe kwimbali yabo yonyango.
Abantwana kunye nabafikisayo
Ukhuseleko kunye nokusebenza kakuhle kwe-lithium orotate kubantwana nakwishumi elivisayo akuzange kumiselwe kakuhle. Ngenxa yoko, ngokuqhelekileyo kucetyiswa ukuba abantu abangaphantsi kweminyaka eyi-18 bagweme ukusebenzisa i-lithium orotate ngaphandle kokuba phantsi kwesikhokelo somboneleli wezempilo onokuhlola ukufaneleka kokusetyenziswa kwayo kwiimeko ezithile. Abantwana kunye nabakwishumi elivisayo banengqwalasela ekhethekileyo yomzimba kunye nophuhliso ekufuneka ithathelwe ingqalelo xa kuqwalaselwa ukusetyenziswa kwaso nasiphi na isongezelelo, kubandakanya i-lithium orotate.
Abantu Abanezifo ze-Thyroid
I-Lithium yaziwa ngokuphazamisa ukusebenza kwe-thyroid, kwaye abantu abaneengxaki ze-thyroid, ezifana ne-hypothyroidism okanye i-hyperthyroidism, kufuneka baqaphele xa beqwalasela ukusetyenziswa kwe-lithium orotate. Iziphumo ze-lithium kumsebenzi we-thyroid zinokwahluka kumntu nomntu, kwaye abantu abaneengxaki ze-thyroid kufuneka basebenze ngokusondeleyo kunye nomboneleli wabo wezempilo ukujonga umsebenzi wabo we-thyroid ukuba bacinga ukusebenzisa i-lithium orotate.
Uyongeza njani iLithium
Ngoko ke, kunokubonwa kule ngxoxo ingentla ukuba ityuwa ye-lithium inefuthe lokukhusela kwiiseli ze-nerve zombini kwi-vivo kunye ne-vitro. Inokuzola kwaye izinzise iimvakalelo, ilawule ukuphazamiseka kwemithambo-luvo, kwaye ingasetyenziselwa ukuthintela isifo sika-Alzheimer, isifo sikaHuntington, ischemia yobuchopho, njl njl. Isifo seCerebrovascular. Ngexesha elifanayo, inokuphucula umsebenzi we-hematopoietic kunye nokuphucula ukusebenza komzimba womntu.
I-lithium yinto yendalo efumaneka kwindalo, ikakhulu ephuma kwiinkozo kunye nemifuno. Ukongezelela, amanzi okusela kwezinye iindawo anomxholo ophezulu we-lithium, onokunika kwakhona i-lithium intake.
Ukongeza kokufumana isixa esincinci se-lithium kwisidlo sakho semihla ngemihla, ungayifumana nakwizongezo.
I-Suzhou Myland Pharm & Nutrition Inc. ibandakanyeke kwishishini lokongezelela isondlo ukususela ngo-1992. Yinkampani yokuqala e-China ukuphuhlisa nokuthengisa isicatshulwa sembewu yomdiliya.
Iminyaka engama-30 yamava kwaye iqhutywa bubuchwephesha obuphezulu kunye nesicwangciso se-R&D esiphuculwe kakhulu, inkampani iphuhlise uluhlu lweemveliso ezikhuphisanayo kwaye ibe sisongezelelo sesayensi yobomi, ukuhlanganiswa kwesiko kunye nenkampani yeenkonzo zokuvelisa.
Ukongeza, iSuzhou Myland Pharm & Nutrition Inc. ikwangumvelisi obhalisiweyo we-FDA. Izixhobo zeR&D zenkampani, izixhobo zemveliso, kunye nezixhobo zohlalutyo zezanamhlanje kwaye zinemisebenzi emininzi kwaye zinokuvelisa iikhemikhali ukusuka kwimilligram ukuya kwiitoni kwisikali, kwaye zithobela imigangatho ye-ISO 9001 kunye neenkcukacha zemveliso ye-GMP.
Ixesha lokuposa: Aug-01-2024
